Increasing influenza and pneumococcal vaccine uptake in the elderly - The Vaccination60+ study

Conditions

J10 J18 R65.1 R65.0 R57.2

Dorothee Heinemeier, Anne Reinhardt, Wolfgang Hanke, Constanze Rossmann, Cornelia Betsch

2025-11-13

Influenza and pneumococcal vaccine hesitancy in the elderly population: results from two representative surveys in Germany

Dorothee Heinemeier, Philipp Schmid, Sarah Eitze, Cornelia Betsch, Vaccination60+ study group

BMC Public Health2025-05-062 citations

10.1186/s12889-025-22441-9

Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60.

Betsch C, Rossmann C, Pletz MW, Vollmar HC, Freytag A, Wichmann O, Hanke R, Hanke W, Heinemeier D, Schmid P, Eitze S, Weber W, Reinhardt A, Küpke NK, Forstner C, Fleischmann-Struzek C, Mikolajetz A, Römhild J, Neufeind J, Rieck T, Suchecka K, Reinhart K.

2018-07-1626 citations

10.1186/s12889-018-5787-9

Interventions

Group 1: Population of the federal state Thuringia, Germany (intervention group): implementation of an evidence-informed campaign to increase vaccination rates of influenza and pneumococcal vaccinatio

Eligibility

Sex/Gender

All

Age

60 Years to No maximum

Inclusion criteria

Inclusion criteria: State of residence: Germany

Exclusion criteria

Exclusion criteria: age <60 years

Design outcomes

Primary

Measure	Time frame
Primary outcomes are reasons for non-vaccination and determinants of vaccination behavior as well as uptake rates of influenza and pneumococcal vaccination. These outcomes are measured by a representative telephone survey in Thuringia and other federal countries, as well as the assessment of vaccination rates using routine data by the Kassenärztliche Vereinigung Thüringen during and after the first and second wave of the intervention (autumn and winter 2017/2018 and 2018/2019).	—

Measure

Time frame

Primary outcomes are reasons for non-vaccination and determinants of vaccination behavior as well as uptake rates of influenza and pneumococcal vaccination. These outcomes are measured by a representative telephone survey in Thuringia and other federal countries, as well as the assessment of vaccination rates using routine data by the Kassenärztliche Vereinigung Thüringen during and after the first and second wave of the intervention (autumn and winter 2017/2018 and 2018/2019).

—

Secondary

Measure	Time frame
Secondary outcomes are the reduction of influenza, pneumonia, pneumococcal bacteremia and sepsis incidence in the target group. As a tertiary outcome the reduction of the economic burden of influenza, pneumonia and sepsis for the healthcare system will be assessed. Secondary and tertiary outcomes are assessed after the intervention using different data sources such as the nationwide DRG statistics by the Federal Statistics Office, the Alertsnet Registry for bloodstream infection in Thuringia, claims data of a major social health insurance (AOK PLUS) and data of the Multidisciplinary Quality Assurance in the Health Care System (SQG data).	—

Measure

Time frame

Secondary outcomes are the reduction of influenza, pneumonia, pneumococcal bacteremia and sepsis incidence in the target group. As a tertiary outcome the reduction of the economic burden of influenza, pneumonia and sepsis for the healthcare system will be assessed. Secondary and tertiary outcomes are assessed after the intervention using different data sources such as the nationwide DRG statistics by the Federal Statistics Office, the Alertsnet Registry for bloodstream infection in Thuringia, claims data of a major social health insurance (AOK PLUS) and data of the Multidisciplinary Quality Assurance in the Health Care System (SQG data).

—

Countries

Germany

Contacts

Public ContactNora Katharina Küpke

Universität Erfurt

nora_katharina.kuepke@uni-erfurt.de+49 361 737-1638

Outcome results

None listed